Description

1-Piperazineethanol, α-(1,3-Dimethyl-7-Xanthinylmethyl)-4-(p-Isopropylbenzyl)-, Benzoate (Ester) is a high-purity, specialized pharmaceutical intermediate with a complex molecular structure designed for targeted synthesis. This compound is critical for ensuring the precise chemical architecture and bioactivity required in advanced drug development. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the synthesis of novel therapeutic agents, particularly within central nervous system (CNS) and cardiovascular research domains.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of proprietary active pharmaceutical ingredients (APIs) for investigational drugs.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization in preclinical research.
• Process Chemistry: Serves as a critical reagent in scale-up and process development for new chemical entities (NCEs).
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of clinical trial materials.
• Academic Research: Utilized in university laboratories for biochemical and pharmacological studies related to xanthine and piperazine derivatives.

Basic Information

Product Name	1-Piperazineethanol, α-(1,3-Dimethyl-7-Xanthinylmethyl)-4-(p-Isopropylbenzyl)-, Benzoate (Ester)
CAS No.	19977-12-9
Molecular Formula	C30H39N5O3
Molecular Weight	517.66 g/mol
Synonyms	4-[4-(4-Isopropylbenzyl)piperazin-1-yl]-1-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)butan-2-yl benzoate; 7-[4-(4-Isopropylbenzyl)-1-piperazinyl]-3-methyl-8-[3-(benzoyloxy)-2-hydroxypropyl]-1H-purine-2,6-dione; 1-Piperazineethanol, α-(1,3-dimethyl-7-xanthinylmethyl)-4-(p-isopropylbenzyl)-, benzoate (ester); A derivative of Pentoxifylline; Contact for additional trade names and abbreviations.
EINECS	Contact for details

Quality Control

Our 1-Piperazineethanol, α-(1,3-Dimethyl-7-Xanthinylmethyl)-4-(p-Isopropylbenzyl)-, Benzoate (Ester) is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical R&D and cGMP manufacturing. Certificates of Analysis (COA) with detailed chromatographic data are provided for every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). This material is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.